JESSICA BEAN: Open Payments
NPI 1861876856 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 65 payments from 16 companies in 2025. Trend: 2023 $1,767 · 2024 $1,605 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $565 |
| AstraZeneca Pharmaceuticals LP | 13 | $368 |
| Lilly USA, LLC | 5 | $94 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Amgen Inc. | 4 | $75 |
| Astellas Pharma US Inc | 2 | $45 |
| PFIZER INC. | 2 | $44 |
| ABBVIE INC. | 2 | $42 |
| Abbott Laboratories | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: Ozempic, FARXIGA, MOUNJARO, GEMTESA, AIRSUPRA, OTEZLA, Veozah, Wegovy.
Industry payments across FL — which companies pay providers there.
